Carlyle and Brighton Park to invest $200m in Indegene.

Investment firms The Carlyle Group and Brighton Park agreed to invest $200m in Indegene, a company offering research and development and management services to healthcare and pharmaceutical enterprises. "We are excited about our partnership with Carlyle and Brighton Park as their collective strengths will bring significant value to Indegene as we build on the deep domain knowledge and vertical technology we have developed over the past 20 years. Carlyle’s commitment to the healthcare sector with their global network and deep pharmaceutical expertise, coupled with Brighton Park’s deep experience in the technology sector and nuanced understanding of our space, makes the two firms the ideal partners to support our company’s continued growth," Manish Gupta, Indegene Co-Founder and CEO.